STOCK TITAN
  1. Home
  2. DBTX

Decibel Therapeutics (DBTX) Stock Price, News & Analysis

DBTX NASDAQ

Company Description

Decibel Therapeutics (NASDAQ: DBTX) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for DBTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
25.1M
Shares outstanding

Latest News

View All
-0.97%

Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update

earnings
-0.24%

Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference

conferences
-0.24%

Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

conferences clinical trial
+4.52%

Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit

conferences
+4.71%

Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

earnings
+1.12%

Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO

clinical trial

Decibel Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, clinical trial, management. View all DBTX news →

SEC Filings

View All

No SEC filings available for DBTX.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

DBTX Company Profile & Sector Positioning

Decibel Therapeutics (DBTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.